The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBatm Advanced Regulatory News (BVC)

Share Price Information for Batm Advanced (BVC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.50
Bid: 17.75
Ask: 18.50
Change: 0.35 (1.93%)
Spread: 0.75 (4.225%)
Open: 18.50
High: 18.50
Low: 18.50
Prev. Close: 18.15
BVC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Secondary Listing on the Tel Aviv Stock Exchange

8 Jul 2019 07:00

RNS Number : 7134E
BATM Advanced Communications Ld
08 July 2019
 

LEI: 213800FLQUB9J289RU66

 

8 July 2019

 

BATM Advanced Communications Limited

("BATM" or "the Group")

 

Secondary Listing on the Tel Aviv Stock Exchange

BATM (LSE: BVC), a leading provider of real-time technologies for networking solutions and medical laboratory systems, announces that, further to its placing to raise $18 million and intention to seek a secondary listing on the Tel Aviv Stock Exchange ("TASE") announced on 24 June, the Group has today applied for the listing of its ordinary shares on TASE and trading is expected to commence on 11 July 2019. Based on its current market capitalisation, BATM expects to become a constituent of the TA-90 index, which is one of TASE's leading indices and tracks the 90 shares with the highest market capitalisation that are not included in the TA-35 index.

 

BATM is pursuing the secondary listing in order to:

· provide a local trading platform for the Israeli-based institutions that have recently become shareholders in the Group;

· expand the accessibility of its shares to a wider pool of investors; and

· increase the breadth and depth of the Group's shareholder base, with the aim of ultimately improving the liquidity and tradability of its shares.

 

The ordinary shares of the Group will continue to trade on the Main List of the London Stock Exchange ("LSE"), where BATM has been listed since 12 July 1999. The shares listed on TASE will be fully transferrable and fungible with those listed on the LSE, the Group's primary listing. BATM is not issuing any new shares in connection with the secondary listing.

 

Dr Zvi Marom, Chief Executive Officer of BATM, said: "This is an exciting time for BATM with great progress being made across our business and listing on TASE will expand the accessibility of our growth story to a wider pool of investors. We are a global company that has its headquarters and extensive operations in Israel and recently raised $18 million from investors in the UK and Israel. As a result, and with the ease of being able to trade between the LSE and TASE platforms, this is a natural step to strengthen our investment profile. By expanding the breadth and depth of our shareholder base, combined with sustained growth, we look forward to increasing the liquidity of our stock and delivering value to all investors."

 

 

Enquiries:

 

BATM Advanced Communications

Dr. Zvi Marom, Chief Executive Officer

+972 9866 2525

Moti Nagar, Chief Financial Officer

Shore Capital Stockbrokers

Mark Percy, Anita Ghanekar

+44 20 7408 4050

Luther Pendragon

Harry Chathli, Claire Norbury, Joe Quinlan

+44 20 7618 9100

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCBRGDRGGGBGCR
Date   Source Headline
14th Apr 20229:30 amRNSAnnual Financial Report
13th Apr 20227:00 amRNSAppointment of Non-Executive Director
4th Apr 20227:00 amRNSTransaction in Own Shares and TVR
18th Mar 20227:00 amRNSStrategic Partnership for Edgility with NEXCOM
17th Mar 202210:30 amRNSResult of General Meeting
10th Mar 202212:30 pmRNSHolding(s) in Company
8th Mar 202211:30 amRNSHolding(s) in Company
28th Feb 20227:00 amRNSFull Year Results
23rd Feb 20227:00 amRNSNotice of General Meeting
21st Feb 20227:00 amRNSStrategic Partnership for Edgility with Advantech
17th Feb 20227:00 amRNSTrading Update and Notice of Results
3rd Feb 202211:23 amRNSClarification on FTSE Nationality Review
3rd Feb 20227:00 amRNSUpdate on FTSE Nationality Review & Share Buyback
31st Jan 20227:00 amRNSUpdate on Ador Diagnostics
17th Jan 20227:00 amRNSUpdate on FTSE Nationality Review
4th Jan 20227:00 amRNSDividend Declaration
4th Jan 20227:00 amRNSTotal Voting Rights
16th Dec 20217:00 amRNSFirst sales of rapid COVID-19 test in Russia
14th Dec 202111:45 amRNSResult of AGM and Dividend Declaration
30th Nov 20217:00 amRNSCOVID-19 tests effective in diagnosing Omicron
25th Nov 20213:00 pmRNSBlock Listing Interim Review
22nd Nov 20213:00 pmRNSNotice of AGM and Dividend Declaration
10th Nov 20217:00 amRNSBATM receives $3.5m cyber security contract
3rd Nov 20217:00 amRNSNew five-year contract for Edgility
1st Nov 20217:00 amRNSBATM receives agri-waste contract in Botswana
7th Oct 20217:00 amRNSStrategic partnership for NFV with AudioCodes
13th Sep 20217:00 amRNSFirst enterprise customer for NFV with $2m order
23rd Aug 20217:00 amRNSInterim Results
12th Aug 20217:00 amRNSNotice of Results
12th Jul 20217:00 amRNSLaunch of Edgility networking NFV-based ecosystem
5th Jul 20217:00 amRNSBATM receives $10m cyber security contract
15th Jun 20217:00 amRNSBATM receives $4.1m cyber security contract
26th May 20217:00 amRNSBlock listing Interim Review
18th May 20217:00 amRNSBATM commences delivery of new COVID-19 tests
19th Apr 202110:25 amRNSAnnual Financial Report
12th Apr 20217:00 amRNSStrategic partnership for NFV
29th Mar 20217:00 amRNSBATM develops molecular diagnostics test for TB
19th Mar 20217:00 amRNSCompletion of Sale of NGSoft
11th Mar 20217:00 amRNSBATM launches no-swab saliva-based COVID-19 test
1st Mar 20217:00 amRNSUpdate on Sale of NGSoft
22nd Feb 20217:00 amRNSFull Year Results
11th Feb 20215:38 pmRNSFTSE Nationality Review
1st Feb 20217:00 amRNSTrading Update and Notice of Results
19th Jan 20217:00 amRNSBATM's NFVTime now available for the public cloud
12th Jan 20217:00 amRNSBATM enters option agreement to sell NGSoft
24th Dec 20207:00 amRNSCOVID-19 test effective in diagnosing new strain
17th Dec 20203:50 pmRNSResult of AGM
15th Dec 20207:00 amRNSUpdate on Ador Diagnostics
7th Dec 20207:00 amRNSDelivery of First Insect Protein Recovery Facility
30th Nov 20203:03 pmRNSTotal Voting Rights and Share Capital

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.